Capital Research files 13G/A for SiriusPoint (0.6%)
SiriusPoint Ltd. disclosure: Capital Research Global Investors files an amendment to state beneficial ownership of 747,968 shares of SiriusPoint common stock, representing 0.6% of the 116,990,288 shares believed to be outstanding.
Rhea-AI Filing Summary
SiriusPoint Ltd. disclosure: Capital Research Global Investors files an amendment to state beneficial ownership of 747,968 shares of SiriusPoint common stock, representing 0.6% of the 116,990,288 shares believed to be outstanding. The filing lists sole voting power and sole dispositive power over the 747,968 shares and is signed May 11, 2026.
Positive
- None.
Negative
- None.
Insights
Large asset manager reports a sub-1% stake in SiriusPoint.
Capital Research Global Investors (CRGI) discloses beneficial ownership of 747,968 shares, or 0.6%, of SiriusPoint's common stock. The filing identifies both sole voting and sole dispositive power for the full holding.
The position size is small relative to the stated 116,990,288 shares outstanding, implying limited shareholder influence from this holding. Subsequent filings would show any material changes in stake size or voting intent.
Key Figures
Key Terms
beneficially owned regulatory
Schedule 13G/A regulatory
sole dispositive power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Capital Research Global Investors report in SiriusPoint (SPNT)?
What form was filed to report this ownership change for SPNT?
What dates are shown in the filing for the SPNT disclosure?
Is CRGI a single entity or a group of affiliated managers?
AI-generated analysis. How Rhea-AI works. Not financial advice.